`

Minerva Biotechnologies

Biotechnology

Specialities :
Cancer research
Immuno-oncology
Stem cell research
And regenerative medicine
revenue-icon Revenue
11M - 100M
funding-icon Total Funding
$4.51M
size-icon Size
11 - 50

Frequently Asked Questions About Minerva Biotechnologies

What does Minerva biotechnologies do?+

Minerva Biotechnologies is a clinical stage biopharmaceutical company focused on developing immunotherapies for solid tumor cancers and cellular therapies for regenerative medicine. NCT04020575 is Minervas first-in-human trial of huMNC2-CAR44, a CAR T that targets the MUC1* growth factor receptor, for the treatment of metastatic breast cancers, 95% of which express a MUC1*. We are now expanding the current clinical trial to include our second CAR-T product that greatly increases persistence. The Company is rapidly accelerating its pipeline that includes next-gen CAR-T products, a straight antibody therapeutic and a small molecule therapeutic which are both for the treatment of cancer metastasis....

What are Minerva biotechnologies's specialties? +

Cancer research,immuno-oncology,stem cell research,and regenerative medicine

What is Minerva biotechnologies's industry? +

Minerva biotechnologies operates in the Biotechnology industry.

What is Minerva biotechnologies's revenue? +

Minerva biotechnologies's revenue is 11m - 100m

What is Minerva biotechnologies's company size? +

Minerva biotechnologies has 11 - 50 employees.

The Go-to Sales Technology According to G2

G2 Badges Map
Get Started With Clodura
Sign Up

Sign Up for Free

Get Started with the Free Forever plan! No credit card needed. Enjoy up to 10,000 free email credits per month at no cost.

Supercharge Your Prospecting

Supercharge Your Prospecting

Start Prospecting from Clodura.AI's database of 600M+ verified B2B contacts and 120M+ direct dials along with 18M+ companies' org charts.

Grow Your Business

Grow Your Business

Unlock the prospect's contact details, including verified email, direct dials, add them to cadence, and close more deals.